- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04288934
Treatment of Spinal Cord Injuries With (AutoBM-MSCs)vs (WJ-MSCs).
August 24, 2021 updated by: Fatima Jamali, University of Jordan
Assessment of Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Spinal Cord Injury (SCI) Patients.
This study aims to assess and compare the safety and effectiveness of Autologous Bone Marrow-Derived MSCs (AutoBM-MSCs) in one group(group A) of SCI who are unlikely to be able to walk independently without treatment after 1 year of SCI, in the other group (group B) to assess the second group of Wharton Jelly derived mesenchymal stem cells ( WJ-MSCs) in the treatment of acute and subacute spinal cord injury (SCI) patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study will be directed by the Cell Therapy Center (CTC) in Jordan, where 20 SCI patients meeting the inclusion criteria will be recruited and divided according to the type of injury into two groups; Group A for patients with complete transection of the spinal cord, and Group B for SCI without a total transaction,10 patients will receive (AutoBM-MSCs)and the other 10 patients with acute and subacute spinal cord injury will receive(WJ-MSCs) by a specialized spine surgeon into the spinal medulla.
The outcomes and improvements will be assessed using the American Spinal Injury Association (ASIA) Impairment Scale (AIS) and the Spinal Cord Independence Measure (SCIM) version III, in addition to blood tests, MRI, and somatosensory evoked potential (SSEP).
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Amman, Jordan
- Cell Therapy Center, University of Jordan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 18-70 years
- Complete SCI grade AIS-A or -B, or incomplete C
- SCI between cervical levels C5 and thoracic level T11
- At least 12 weeks since time of injury
- Prediction rule score of 10 or less
- Cognitively unaffected
- Motivated for stem cell transplantation
Exclusion Criteria:
- Reduced cognition
- Age under 18 years or above 70 years
- Significant osteoporosis in spine and/or joints
- Pregnancy (Adequate contraceptive use is required for women in fertile age)
- Anoxic brain injury
- Neurodegenerative diseases
- Evidence of meningitis
- Positive serology for HIV, HBV, HCV, or Syphilis.
- Medical Complications that contraindicate surgery, including major respiratory complications.
- Use of metal implants close to vascular structures (such as cardiac pacemaker or prosthesis) that contraindicate MRI.
- Other medical conditions which can interfere with stem cell transplantation
- Inability to provide informed consent.
- Uncorrected vision
- Cardiac abnormalities and uncontrolled hypertension
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: patients with complete transection of the spinal cord
This group of patients with complete transection of the spinal cord group will then be subdivided into 2 subgroups with of 5 patients each; the 1st subgroup will be the patients with chronic SCI and the 2nd subgroup will be for the patients with subacute SCI.
All patients will receive AutoBM-MSCs by a specialized spine surgeon into the spinal medulla.
|
MSCs collection from patients owns marrow using a volume of 20 ml of bone marrow obtained from iliac crest of SCI patients under local anesthesia.
Manipulations of blood and bone marrow are to be done according to Good Laboratory Practice (GLP) using the gradient sedimentation method.
|
ACTIVE_COMPARATOR: patients with SCI without total transaction.
This group will then be subdivided into 2 subgroups with of 5 patients each; the 1st subgroup will be the patients with chronic SCI and the 2nd subgroup will be for the patients with subacute SCI.
All patients will receive WJ-MSCs by a specialized spine surgeon into the spinal medulla.
|
MSCs collection from patients owns marrow using a volume of 20 ml of bone marrow obtained from iliac crest of SCI patients under local anesthesia.
Manipulations of blood and bone marrow are to be done according to Good Laboratory Practice (GLP) using the gradient sedimentation method.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SCI evaluation and patients follow up
Time Frame: 3 months
|
the (ASIA)/(ISNCSCI) to evaluate any motor or neurological changes, and the spinal cord independence measure (SCIM III) score to evaluate the effect on daily activities .these tests will be repeated every 3 months. blood samples will be withdrawn from patients as well to detect any biomarkers. |
3 months
|
SCI evaluation and MSCs transplantation
Time Frame: 6-12 months
|
post MSCs transplantation, patients' spine will be imaged using 3 Tesla MRI and compared to baseline.
|
6-12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 15, 2017
Primary Completion (ACTUAL)
April 15, 2020
Study Completion (ACTUAL)
September 20, 2020
Study Registration Dates
First Submitted
September 23, 2019
First Submitted That Met QC Criteria
February 27, 2020
First Posted (ACTUAL)
February 28, 2020
Study Record Updates
Last Update Posted (ACTUAL)
August 25, 2021
Last Update Submitted That Met QC Criteria
August 24, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SCICTC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Shepherd Center, Atlanta GACompletedInjuries, Spinal Cord
-
Wroclaw Medical UniversityInstitute of Immunology and Experimental Therapy of the Polish Academy of... and other collaboratorsUnknownComplete Spinal Cord InjuriesPoland
-
Lineage Cell Therapeutics, Inc.CompletedCervical Spinal Cord Injury | Spine Injury | Spinal Cord TraumaUnited States
Clinical Trials on Collection and expansion of BM-MSC
-
National University of MalaysiaCytopeutics Sdn. Bhd.UnknownCritical Limb IschemiaMalaysia
-
Van Hanh General HospitalUnknownType 2 Diabetes MellitusVietnam
-
Stem Med Pte. Ltd.Parkway Cancer Centre; Asian American Liver Centre; Desmond Wai Liver & Gastrointestinal...Recruiting
-
Ukraine Association of BiobankActive, not recruitingLiver CirrhosisUkraine
-
Mahidol UniversityMinistry of Health, ThailandCompleted
-
Campus Bio-Medico UniversityFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Center for Outcomes...RecruitingChronic Low-back Pain | Intervertebral Disc DegenerationItaly
-
Campus Bio-Medico UniversityFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Center for Outcomes...Active, not recruitingChronic Low-back Pain | Intervertebral Disc DegenerationItaly
-
Indonesia UniversityDr Cipto Mangunkusumo General HospitalUnknown
-
Universidad Central de VenezuelaInstituto Venezolano de Investigaciones CientificasCompletedApical Periodontitis | Pulp NecrosesVenezuela
-
Mahidol UniversityNot yet recruitingRetinitis PigmentosaThailand